The Effect of the Back-Pressure Changes in an Exhaust System on Vibration When Attaching a Variable Device during Idling.

The vibration of the ignition frequency component of the engine during idling causes driver discomfort. To minimize this, an optimal exhaust system with a variable device that can exert optimal pressure is required. In this study, the geometry of the variable device was designed in orifice and cylinder types. Next, the designed variable devices were implemented in a conventional exhaust system with an X chamber. A comparative analysis was conducted to propose an optimal geometry through back-pressure and vibration measurements. During the experiment, the orifice geometry exhibited higher back pressure than the conventional geometry and a large difference in back pressure before and at the exhaust gas merging position. Furthermore, the orifice geometry showed a 2.56% increase in the vibration of the 1X component in the Y-axis direction. By contrast, the cylinder geometry exhibited slightly higher back pressure than the conventional geometry and the smallest difference in back pressure before and at the exhaust gas merging position. The cylinder geometry showed a 2.45% reduction in the vibration of the 1X component in the Y-axis direction.

Breast Cancer Estimate Modeling via PDE Thermal Analysis Algorithms.

The significance of this study lies in the importance of (1) nondestructive testing in defect studies and (2) securing the reliability of breast cancer prediction through thermal analysis in nondestructive testing. Most nondestructive tests have negative effects on the human body. Moreover, the precision and accuracy of such tests are poor. This study analyzes these drawbacks and increases the reliability of such methods. A theoretical model was constructed, by which simulated inner breast tissue was observed in a nondestructive way through thermal analysis, and the presence and extent of simulated breast cancer were estimated based on the thermal observations. Herein, we studied the medical diagnosis of breast cancer by creating a theoretical environment that simulated breast cancer in a real-world setting; the model used two-dimensional modeling and partial differential equation (PDE) thermal analysis. Our theoretical analysis, based on partial differential equations, allowed us to demonstrate that non-wounding defect detection is possible and, in many ways, preferable. The main contribution of this paper lies in studying long-term estimates. In addition, the model in this study can be extended to predict breast cancer through pure heat and can also be used for various other cancer and tumor analyses in the human body.

Highly Efficient Colored Perovskite Solar Cells Integrated with Ultrathin Subwavelength Plasmonic Nanoresonators.

Highly efficient colored perovskite solar cells that exploit localized surface plasmon resonances in ultrathin subwavelength plasmonic nanoresonators are demonstrated. Localized resonances in ultrathin metal nano-strip optical resonators consisting of an array of metallic subwavelength nanowires on a transparent substrate, fabricated by using low-cost nanoimprint lithography over a large area, lead to a sharp peak in a reflection spectrum for distinctive color generation with angle-insensitive property up to 60°, and simultaneously transmit the complementary spectrum of visible light that can be efficiently harvested by the perovskite solar cells for electric power generation. The plasmonic color filter-integrated perovskite solar cells provide 10.12%, 8.17% and 7.72% of power conversion efficiencies with capabilities of creating vivid reflective red, green and blue colors. The scheme described in this work could be applied to a variety of applications such as power-generating decorations, tandem cells, power-saving wearable devices and energy-efficient reflective display technologies.

LBEC0101, A Proposed Etanercept Biosimilar: Pharmacokinetics, Immunogenicity, and Tolerability Profiles Compared with a Reference Biologic Product in Healthy Male Subjects.

OBJECTIVES: We performed this study to compare the pharmacokinetic (PK), immunogenicity, and tolerability profiles of etanercept between LBEC0101, a proposed biosimilar, and Enbrel®, the reference biological product. METHODS: A randomized, double-blind, single-dose, two-treatment, two-period, two-sequence, crossover study was conducted in 48 healthy males. In each period, a single dose of LBEC0101 or Enbrel® was subcutaneously injected at 25 mg and serial blood samples for PK evaluation were collected up to 648 h post-dose. Serum etanercept concentrations and anti-drug antibodies (ADA) were measured using an enzyme-linked immunosorbent assay and an affinity capture elution assay. Log-transformed maximum concentration (C max) and area under the concentration-time curve (AUCinf) were compared. Tolerability was also evaluated. RESULTS: The serum concentration-time profiles were almost overlapped between LBEC0101 and Enbrel®. Geometric mean ratio (90% confidence intervals) for C max and AUCinf of LBEC0101 to Enbrel® were 1.02 (0.92-1.13) and 0.96 (0.87-1.05), respectively, which were within a conventional bioequivalence criteria of 0.80-1.25. ADA development was also comparable. Both drugs were well tolerated. CONCLUSIONS: LBEC0101 showed similar PK, immunogenicity, and tolerability profiles to Enbrel® after a single subcutaneous injection in healthy males. LBEC0101 can be further developed as a potential etanercept biosimilar (ClinicalTrial.gov identifier: NCT01725620).

A randomized, double-blind, single-dose, two-arm, parallel study comparing pharmacokinetics, immunogenicity and tolerability of branded adalimumab and its biosimilar LBAL in healthy male volunteers.

OBJECTIVES: This study aimed to compare the pharmacokinetics (PK), immunogenicity, and tolerability of LBAL, a biosimilar of adalimumab, with the originator, Humira®, in healthy volunteers. METHODS: A randomized, double-blind, single-dose, two-arm, parallel-group study was conducted in 116 healthy subjects. They randomly received a single subcutaneous (SC) 40 mg injection of LBAL or Humira. Blood samples were collected for PK and immunogenicity assessment. PK parameters were determined using the noncompartmental method, and primary endpoint parameters were compared using the point estimates and 90% confidence intervals (CIs) of the geometric mean ratios (GMRs). Tolerability was also evaluated. RESULTS: The PK characteristics of the test and reference drugs were comparable. The GMR (90% CIs) for Cmax and AUCinf of LBAL to Humira were 1.01 (0.92-1.11) and 0.96 (0.83-1.10), respectively, which were within the conventional bioequivalence criteria of 0.80-1.25. No significant differences occurred in the frequency of subjects with anti-adalimumab antibody-positive responses between both drugs. Tolerability profiles including adverse events were also comparable. CONCLUSION: The PK characteristics of the biosimilar LBAL and the originator Humira were similar. LBAL and Humira did not show significant differences in immunogenicity and both were well tolerated after a single SC injection.

A Nondestructive Evaluation Method: Measuring the Fixed Strength of Spot-Welded Joint Points by Surface Electrical Resistivity.

Destructive tests are generally applied to evaluate the fixed strength of spot-welding nuggets of zinc-plated steel (which is a widely used primary structural material for automobiles). These destructive tests, however, are expensive and time-consuming. This paper proposes a nondestructive method for evaluating the fixed strength of the welded joints using surface electrical resistance. A direct current nugget-tester and probes have been developed by the authors for this purpose. The proposed nondestructive method uses the relative decrease in surface electrical resistance, α. The proposed method also considers the effect of the corona bond. The nugget diameter is estimated by two factors: RQuota, which is calculated from variation of resistance, and a constant that represents the area of the corona bond. Since the maximum tensile strength is correlated with the nugget diameter, it can be inferred from the estimated nugget diameter. When appropriate measuring conditions for the surface electrical resistance are chosen, the proposed method can effectively evaluate the fixed strength of the spot-welded joints even if the steel sheet is zinc-plated.

High-level expression of human glycosyltransferases in insect cells as biochemically active form.

cDNAs, encoding human beta1,4-galactosyltransferase (hGalT I, EC 2.4.1.22), human Galbeta1,3(4)-GlcNAc alpha2,3-sialyltransferase (hST3GalIII, EC 2.4.99), and human Galbeta1,4-GlcNAc alpha2,6-sialyltransferase (hST6Gal I, EC 2.4.99.1), were cloned from human cell lines. In order to express these glycosyltransferases as secreted form in insect cells, cDNAs were inserted into a novel baculovirus transfer vector equipped with the mouse IgM signal peptide and IgG binding domain of the Staphylococcus aureus protein A as an N-terminal fusion partner. About 14 mg hGalT I, 8 mg hST3GalIII, and 6.4 mg hST6Gal I were purified from 1 liter of recombinant baculovirus infected insect cell culture media. The specific activities of recombinant hGalT I and hST6Gal I were determined as 0.65 and 1.6 U/mg protein, respectively. These results indicated that the recombinant hGalT I and hST6Gal I retained enzyme activities at similar level to those of the authentic one although they were fused with the IgG binding domain at the N-terminus. Taken together, the mouse IgM signal peptide and IgG binding domain of the protein A could be efficiently used as an N-terminus fusion partner for the over-expression of heterologous proteins in insect cells.